๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

VALIDATION OF A PREDICTION MODEL AND ITS PREDICTORS FOR THE HISTOLOGY OF RESIDUAL MASSES IN NONSEMINOMATOUS TESTICULAR CANCER

โœ Scribed by VERGOUWE, YVONNE; STEYERBERG, EWOUT W.; FOSTER, RICHARD S.; HABBEMA, J. DIK F.; DONOHUE, JOHN P.


Book ID
122873687
Publisher
Lippincott Williams and Wilkins
Year
2001
Tongue
English
Weight
105 KB
Volume
165
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Prediction models for the histology of r
โœ Ewout W. Steyerberg; H. Jan Keizer; J. Dik F. Habbema ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 105 KB ๐Ÿ‘ 2 views

Patients with metastatic non-seminomatous testicular cancer can be cured by cisplatin-based chemotherapy. After chemotherapy, surgical resection is a generally accepted treatment to remove remnants of the initial metastases since residual tumor may still be present (mature teratoma or viable cancer

Resection of small, residual retroperito
โœ Ewout W. Steyerberg; Phillip B. Marshall; H. Jan Keizer; J. Dik F. Habbema ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 190 KB ๐Ÿ‘ 2 views

## BACKGROUND. After chemotherapy for metastatic, nonseminomatous testicular cancer, small, retroperitoneal lymph nodes still harbor mature teratoma or viable cancer cells in less than half of patients with normal tumor markers. Surgical resection is an effective treatment to remove residual masse